REQUEST A DEMO
Total
USD $0.00
Search more companies

Jiangsu Hengrui Medicine Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Jiangsu Hengrui Medicine Co., Ltd Profile Updated: February 16, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Chinese Download a sample report

The company is the largest production base of anticancer drugs, the state designated narcotics manufacturer and is an hi-tech enterprise recognized by Science and Technology Committee with a post-doctoral research station. It is also a national "863 Plan" industrial base. The main products are: oncology, cardiovascular medicine, narcotic pain medicine etc. Some numbers of the products have passed national GMP and U.S. FDA certification. Through technology transfer, joint innovation, self-development and other forms of development, the company has now owned more than 90 new drug certificates including class 1 and class 2 certificates. Four of the company’s projects have been included in the national "863 Plan". A number of the company developed patented drugs and innovative drugs are under or will be under clinical trials.

Headquarters
38 Huanghe R. Lianyungang E.D.A. Jiangsu
Lianyungang; Jiangsu; Postal Code: 222000

Contact Details: Purchase the Jiangsu Hengrui Medicine Co., Ltd report to view the information.

Website: http://http://www.hrs.com.cn

Basic Information
Total Employees:
Purchase the Jiangsu Hengrui Medicine Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Jiangsu Hengrui Medicine Co., Ltd report to view the information.
Registered Capital:
Purchase the Jiangsu Hengrui Medicine Co., Ltd report to view the information.
Financial Auditors:
Purchase the Jiangsu Hengrui Medicine Co., Ltd report to view the information.
Ratings:
Purchase the Jiangsu Hengrui Medicine Co., Ltd report to view the information.
Incorporation Date:
April 28, 1997
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
24.15%
Purchase this report to view the information.
14.96%
Purchase this report to view the information.
11.58%
Purchase this report to view the information.
4.87%
Purchase this report to view the information.
4.12%
Subsidiaries
Xiamen Yulian Health Industry Investment Partnership (Limited Partnership)
Company Performance
Financial values in the chart are available after Jiangsu Hengrui Medicine Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
25.37%
Total operating revenue
24.83%
Operating profit (EBIT)
11.68%
EBITDA
12.3%
Net Profit (Loss) for the Period
14.56%
Total assets
23.97%
Total equity
23.62%
Operating Profit Margin (ROS)
-3.19%
Net Profit Margin
-2.04%
Return on Equity (ROE)
-0.36%
Quick Ratio
-0.18%
Cash Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?